Pharmaceutical industry payments and assisted reproduction in Australia: A retrospective observational study

Abstract

Objectives To investigate the extent and nature of pharmaceutical industry payments related to fertility and assisted reproduction in Australia. Design and setting This retrospective observational study employed four databases compiled from publicly available pharmaceutical industry transparency reports on educational event sponsorship (October 2011-April 2018), payments to healthcare professionals (October 2015-April 2018) and patient group support (January 2013-December 2017). Analyses were restricted to fertility-related payments by two major manufacturers of fertility medicines in Australia: Merck Serono and Merck, Sharp and Dohme (MSD). Primary and secondary outcome measures Descriptive..